+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

C-Reactive Protein Testing Market Research Report by End-user, by Assay Type, by Detection Range, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 5234054
  • Report
  • July 2021
  • Region: Global
  • 186 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global C-Reactive Protein Testing Market will Grow to USD 2,141.02 Million by 2026, at a CAGR of 12.22%

FEATURED COMPANIES

  • Abaxis, Inc.
  • Aidian
  • Bio-Techne
  • EKF Diagnostics
  • HORIBA, Ltd.
  • Randox Laboratories Ltd.
The Global C-Reactive Protein Testing Market size was estimated at USD 1,071.63 Million in 2020 and expected to reach USD 1,199.03 Million in 2021, at a Compound Annual Growth Rate (CAGR) 12.22% to reach USD 2,141.02 Million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the C-Reactive Protein Testing to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on End-user, the C-Reactive Protein Testing Market was studied across Assisted Living Healthcare Facilities, Clinics, Home, Hospitals, and Laboratories. The Clinics is further studied across Entity.
  • Based on Disease Area, the C-Reactive Protein Testing Market was studied across Cancer, Cardiovascular Diseases, Endometriosis, Inflammatory Bowel Disease, Lupus, and Rheumatoid Arthritis.
  • Based on Assay Type, the C-Reactive Protein Testing Market was studied across Chemiluminescence Immunoassay, ELISA, Immunoturbidimetric Assay, and Radioimmunoassay. The Chemiluminescence Immunoassay is further studied across Free T3, Free T4, and Thyrotropin (TSH) levels. The ELISA is further studied across Clinical and Nonclinical. The Radioimmunoassay is further studied across Autoantibodies Against Thyrotropin Receptor, Human Serum Thyroglobulin Autoantibodies, and Thyroperoxidase Autoantibodies.
  • Based on Detection Range, the C-Reactive Protein Testing Market was studied across cCRP, Conventional CRP, and hs-CRP.
  • Based on Region, the C-Reactive Protein Testing Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the C-Reactive Protein Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global C-Reactive Protein Testing Market, including Abaxis, Inc., Abbott Laboratories, Abcam plc, Aidian, Alere Inc., Beckman Coulter, Inc., Bio-Techne, BODITECH MED, INC, Danaher, EKF Diagnostics, Eurolyser Diagnostica GmbH, F. Hoffmann-La Roche Ltd., Getein Biotech, Inc., HORIBA, Ltd., Laboratory Corporation of America Holdings (LabCorp), Merck KGaA, Merck Millipore, Ortho Clinical Diagnostics, Quest Diagnostics Incorporated, Randox Laboratories Ltd., SD Biosensor, INC., Siemens, Sigma-Aldrich Co. LLC, and Thermo Fisher Scientific, Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global C-Reactive Protein Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global C-Reactive Protein Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global C-Reactive Protein Testing Market?
4. What is the competitive strategic window for opportunities in the Global C-Reactive Protein Testing Market?
5. What are the technology trends and regulatory frameworks in the Global C-Reactive Protein Testing Market?
6. What is the market share of the leading vendors in the Global C-Reactive Protein Testing Market?
7. What modes and strategic moves are considered suitable for entering the Global C-Reactive Protein Testing Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abaxis, Inc.
  • Aidian
  • Bio-Techne
  • EKF Diagnostics
  • HORIBA, Ltd.
  • Randox Laboratories Ltd.
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. End-user Outlook
3.4. Disease Area Outlook
3.5. Assay Type Outlook
3.6. Detection Range Outlook
3.7. Region Outlook
3.8. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing R&D for C-reactive protein testing
5.1.1.2. Need to measure inflammation caused by a wide variety of conditions, from infection to cancer
5.1.1.3. Rising incidence of chronic disorders
5.1.2. Restraints
5.1.2.1. Availability of more commercialised alternative disease testing methods
5.1.3. Opportunities
5.1.3.1. Technological advancements pertaining to conventional CRP tests
5.1.3.2. Growing attrctiveness of point-of-care tests
5.1.4. Challenges
5.1.4.1. Careful administration and handling requirements
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. C-Reactive Protein Testing Market, by End-user
6.1. Introduction
6.2. Assisted Living Healthcare Facilities
6.3. Clinics
6.3.1. Entity
6.3.1.1. Physician Offices
6.3.1.2. Small Clinics
6.4. Home
6.5. Hospitals
6.6. Laboratories

7. C-Reactive Protein Testing Market, by Disease Area
7.1. Introduction
7.2. Cancer
7.3. Cardiovascular Diseases
7.4. Endometriosis
7.5. Inflammatory Bowel Disease
7.6. Lupus
7.7. Rheumatoid Arthritis

8. C-Reactive Protein Testing Market, by Assay Type
8.1. Introduction
8.2. Chemiluminescence Immunoassay
8.2.1. Free T3
8.2.2. Free T4
8.2.3. Thyrotropin (TSH) levels
8.3. ELISA
8.3.1. Clinical
8.3.2. Nonclinical
8.4. Immunoturbidimetric Assay
8.5. Radioimmunoassay
8.5.1. Autoantibodies Against Thyrotropin Receptor
8.5.2. Human Serum Thyroglobulin Autoantibodies
8.5.3. Thyroperoxidase Autoantibodies

9. C-Reactive Protein Testing Market, by Detection Range
9.1. Introduction
9.2. cCRP
9.3. Conventional CRP
9.4. hs-CRP

10. Americas C-Reactive Protein Testing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific C-Reactive Protein Testing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Thailand

12. Europe, Middle East & Africa C-Reactive Protein Testing Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Abaxis, Inc.
14.2. Abbott Laboratories
14.3. Abcam plc
14.4. Aidian
14.5. Alere Inc.
14.6. Beckman Coulter, Inc.
14.7. Bio-Techne
14.8. BODITECH MED, INC
14.9. Danaher
14.10. EKF Diagnostics
14.11. Eurolyser Diagnostica GmbH
14.12. F. Hoffmann-La Roche Ltd.
14.13. Getein Biotech, Inc.
14.14. HORIBA, Ltd.
14.15. Laboratory Corporation of America Holdings (LabCorp)
14.16. Merck KGaA
14.17. Merck Millipore
14.18. Ortho Clinical Diagnostics
14.19. Quest Diagnostics Incorporated
14.20. Randox Laboratories Ltd.
14.21. SD Biosensor, INC.
14.22. Siemens
14.23. Sigma-Aldrich Co. LLC
14.24. Thermo Fisher Scientific, Inc.

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2020 (USD MILLION)
FIGURE 3. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2020 (USD MILLION)
FIGURE 4. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE , 2020 (USD MILLION)
FIGURE 6. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY REGION, 2020 (USD MILLION)
FIGURE 7. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 8. GLOBAL C-REACTIVE PROTEIN TESTING MARKET: MARKET DYNAMICS
FIGURE 9. GLOBAL C-REACTIVE PROTEIN TESTING MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 10. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
FIGURE 11. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2020 VS 2026 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2026
FIGURE 13. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSISTED LIVING HEALTHCARE FACILITIES, 2018-2026 (USD MILLION)
FIGURE 14. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSISTED LIVING HEALTHCARE FACILITIES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 15. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, 2018-2026 (USD MILLION)
FIGURE 16. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 17. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, 2018-2026 (USD MILLION)
FIGURE 18. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 19. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY PHYSICIAN OFFICES, 2018-2026 (USD MILLION)
FIGURE 20. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY PHYSICIAN OFFICES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 21. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY SMALL CLINICS, 2018-2026 (USD MILLION)
FIGURE 22. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY SMALL CLINICS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 23. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY HOME, 2018-2026 (USD MILLION)
FIGURE 24. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY HOME, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 25. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
FIGURE 26. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 27. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY LABORATORIES, 2018-2026 (USD MILLION)
FIGURE 28. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY LABORATORIES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 29. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2020 VS 2026 (%)
FIGURE 30. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2020 VS 2026 (USD MILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2026
FIGURE 32. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CANCER, 2018-2026 (USD MILLION)
FIGURE 33. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CANCER, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 34. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2026 (USD MILLION)
FIGURE 35. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 36. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENDOMETRIOSIS, 2018-2026 (USD MILLION)
FIGURE 37. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENDOMETRIOSIS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 38. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, 2018-2026 (USD MILLION)
FIGURE 39. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 40. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY LUPUS, 2018-2026 (USD MILLION)
FIGURE 41. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY LUPUS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 42. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2026 (USD MILLION)
FIGURE 43. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 44. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2020 VS 2026 (%)
FIGURE 45. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2026
FIGURE 47. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2026 (USD MILLION)
FIGURE 48. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 49. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY FREE T3, 2018-2026 (USD MILLION)
FIGURE 50. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY FREE T3, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 51. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY FREE T4, 2018-2026 (USD MILLION)
FIGURE 52. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY FREE T4, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 53. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY THYROTROPIN (TSH) LEVELS, 2018-2026 (USD MILLION)
FIGURE 54. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY THYROTROPIN (TSH) LEVELS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 55. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2026 (USD MILLION)
FIGURE 56. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 57. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICAL, 2018-2026 (USD MILLION)
FIGURE 58. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICAL, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 59. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY NONCLINICAL, 2018-2026 (USD MILLION)
FIGURE 60. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY NONCLINICAL, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 61. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY IMMUNOTURBIDIMETRIC ASSAY, 2018-2026 (USD MILLION)
FIGURE 62. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY IMMUNOTURBIDIMETRIC ASSAY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 63. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2026 (USD MILLION)
FIGURE 64. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 65. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY AUTOANTIBODIES AGAINST THYROTROPIN RECEPTOR, 2018-2026 (USD MILLION)
FIGURE 66. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY AUTOANTIBODIES AGAINST THYROTROPIN RECEPTOR, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 67. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY HUMAN SERUM THYROGLOBULIN AUTOANTIBODIES, 2018-2026 (USD MILLION)
FIGURE 68. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY HUMAN SERUM THYROGLOBULIN AUTOANTIBODIES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 69. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY THYROPEROXIDASE AUTOANTIBODIES, 2018-2026 (USD MILLION)
FIGURE 70. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY THYROPEROXIDASE AUTOANTIBODIES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 71. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE , 2020 VS 2026 (%)
FIGURE 72. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE , 2020 VS 2026 (USD MILLION)
FIGURE 73. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE , 2026
FIGURE 74. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CCRP, 2018-2026 (USD MILLION)
FIGURE 75. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CCRP, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 76. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CONVENTIONAL CRP, 2018-2026 (USD MILLION)
FIGURE 77. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CONVENTIONAL CRP, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 78. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY HS-CRP, 2018-2026 (USD MILLION)
FIGURE 79. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY HS-CRP, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 80. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 81. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 82. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 83. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 84. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 85. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 86. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 87. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 88. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 89. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 90. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 91. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 92. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 93. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 94. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 95. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 96. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 97. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 98. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 99. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 100. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 101. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 102. QATAR C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 103. RUSSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 104. SAUDI ARABIA C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 105. SOUTH AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 106. SPAIN C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 107. UNITED ARAB EMIRATES C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 108. UNITED KINGDOM C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 109. GLOBAL C-REACTIVE PROTEIN TESTING MARKET: FPNV POSITIONING MATRIX
FIGURE 110. GLOBAL C-REACTIVE PROTEIN TESTING MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 111. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL C-REACTIVE PROTEIN TESTING MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL C-REACTIVE PROTEIN TESTING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSISTED LIVING HEALTHCARE FACILITIES, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENTITY, BY REGION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY PHYSICIAN OFFICES, BY REGION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY SMALL CLINICS, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY HOME, BY REGION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENDOMETRIOSIS, BY REGION, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2018-2026 (USD MILLION)
TABLE 18. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY LUPUS, BY REGION, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2026 (USD MILLION)
TABLE 20. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2026 (USD MILLION)
TABLE 21. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2026 (USD MILLION)
TABLE 22. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY FREE T3, BY REGION, 2018-2026 (USD MILLION)
TABLE 23. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY FREE T4, BY REGION, 2018-2026 (USD MILLION)
TABLE 24. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY THYROTROPIN (TSH) LEVELS, BY REGION, 2018-2026 (USD MILLION)
TABLE 25. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2026 (USD MILLION)
TABLE 26. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2026 (USD MILLION)
TABLE 27. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY NONCLINICAL, BY REGION, 2018-2026 (USD MILLION)
TABLE 28. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY IMMUNOTURBIDIMETRIC ASSAY, BY REGION, 2018-2026 (USD MILLION)
TABLE 29. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2026 (USD MILLION)
TABLE 30. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY AUTOANTIBODIES AGAINST THYROTROPIN RECEPTOR, BY REGION, 2018-2026 (USD MILLION)
TABLE 31. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY HUMAN SERUM THYROGLOBULIN AUTOANTIBODIES, BY REGION, 2018-2026 (USD MILLION)
TABLE 32. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY THYROPEROXIDASE AUTOANTIBODIES, BY REGION, 2018-2026 (USD MILLION)
TABLE 33. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE , 2018-2026 (USD MILLION)
TABLE 34. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CCRP, BY REGION, 2018-2026 (USD MILLION)
TABLE 35. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CONVENTIONAL CRP, BY REGION, 2018-2026 (USD MILLION)
TABLE 36. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY HS-CRP, BY REGION, 2018-2026 (USD MILLION)
TABLE 37. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 42. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 43. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 44. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 45. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 46. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 47. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 48. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 49. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 50. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 51. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 52. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 53. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 55. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 56. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 57. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 58. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 59. QATAR C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 60. RUSSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 61. SAUDI ARABIA C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 62. SOUTH AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 63. SPAIN C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 64. UNITED ARAB EMIRATES C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 65. UNITED KINGDOM C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 66. GLOBAL C-REACTIVE PROTEIN TESTING MARKET: SCORES
TABLE 67. GLOBAL C-REACTIVE PROTEIN TESTING MARKET: BUSINESS STRATEGY
TABLE 68. GLOBAL C-REACTIVE PROTEIN TESTING MARKET: PRODUCT SATISFACTION
TABLE 69. GLOBAL C-REACTIVE PROTEIN TESTING MARKET: RANKING
TABLE 70. GLOBAL C-REACTIVE PROTEIN TESTING MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 71. GLOBAL C-REACTIVE PROTEIN TESTING MARKET: MERGER & ACQUISITION
TABLE 72. GLOBAL C-REACTIVE PROTEIN TESTING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 73. GLOBAL C-REACTIVE PROTEIN TESTING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 74. GLOBAL C-REACTIVE PROTEIN TESTING MARKET: INVESTMENT & FUNDING
TABLE 75. GLOBAL C-REACTIVE PROTEIN TESTING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 76. GLOBAL C-REACTIVE PROTEIN TESTING MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Abaxis, Inc.
  • Abbott Laboratories
  • Abcam plc
  • Aidian
  • Alere Inc.
  • Beckman Coulter, Inc.
  • Bio-Techne
  • BODITECH MED, INC
  • Danaher
  • EKF Diagnostics
  • Eurolyser Diagnostica GmbH
  • F. Hoffmann-La Roche Ltd.
  • Getein Biotech, Inc.
  • HORIBA, Ltd.
  • Laboratory Corporation of America Holdings (LabCorp)
  • Merck KGaA
  • Merck Millipore
  • Ortho Clinical Diagnostics
  • Quest Diagnostics Incorporated
  • Randox Laboratories Ltd.
  • SD Biosensor, INC.
  • Siemens
  • Sigma-Aldrich Co. LLC
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll